Envoy Medical enters $15M at-the-market equity offering with Roth Capital

Envoy Medical, Inc.

ATM agreement with Roth Capital Partners for up to $15M of Class A common stock.
Sales agent compensation is 3.0% of gross proceeds; $50K expense cap.
Shares sold at market prices; no minimum obligation to sell.
Offering made under effective S-3 registration filed Oct 2024.
Company may suspend sales at any time; proceeds for general corporate purposes.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.